Dermaheal Dark Circle Solution (5 vials x 1,5 ml)

The solution acts by inhibiting the production of melanin and inducing the synthesis of collagen and elastin. The bio-mimetic peptides stimulate blood microcirculation, which helps to clear "stagnant" vascular shadows under the eyes. This biological repair mechanism is different from the physical displacement found in traditional volumizing fillers, focusing instead on skin quality and tone.

The formulation contains Oligopeptide-34 (CG-TGP2), Oligopeptide-24 (CG-EDP3), Decapeptide-4 (CG-IDP2), Licorice Root Extract, and Mulberry Bark Extract.

The standard protocol involves one session per week for a period of 4 weeks. Typically, 1.5 ml (one vial) is used per treatment to cover both periorbital areas. Practitioners should evaluate if targeted micro-dosing is appropriate for minor shadowing. For maintenance, one session every 2-3 months is recommended to sustain the brightening effect.

Common reactions include temporary redness, minor swelling, and potential purple bruising at the micro-injection sites. These effects are generally mild and resolve within 24–48 hours. Patients should follow our expert aftercare guide to monitor the healing process. Any persistent irritation or severe pain should be evaluated according to standard clinical safety protocols.

Avoid alcohol for 24h before and after the procedure. Alcohol acts as a vasodilator, which can increase the risk of post-injection swelling and worsen bruising in the highly vascular under-eye area.

This treatment is strictly contraindicated. No clinical safety data exists for peptide-based mesotherapy during pregnancy. We defer elective aesthetic procedures until after the nursing period to ensure the highest safety standards.